Winning in the 20s: How access needs to evolve. Access has become the front and center topic for the pharmaceutical industry. Majority of pharma companies now have explicit goals and commitments to ...
FDA Approves Expanded Indication of Jaypirca for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma As affordability, access, and transparency reshape U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback